Skip to main content
Markets
/
ASTRAZEN · NSE
Market openNSE | BSE
Loading live market indices
AS
NSE · Equity shares · Biotechnology & Drugs

AstraZeneca Pharma India Ltd ASTRAZEN

NSE:INR 8,075.5Recorded price
BSE:INR 8,074Recorded price
Not available · Not available
Advanced chart
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections7 of 9 availableMissing source values remain unavailable, never zero-filled.
Snapshot

Price and key statistics

Reported and computed values remain separate; missing values are not converted to zero.

Previous closeData unavailable
Day rangeINR 8,074 — INR 8,132.05
52-week rangeINR 7,630 — INR 9,850
VolumeNot available
Market cap20,400.82
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)2,275.58
Net Income (INR Cr)187.52
EPS76.61

Research path: Interpret AstraZeneca Pharma India Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.

AI and Advanced

AI analysis and Advanced tools for ASTRAZEN

Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.

AI analysisReview the complete evidence-led AI research workflow.Generate reportCreate a versioned report with entitlement and credit checks.Open AI ChatContinue a grounded conversation with the instrument in context.Advanced modulesOpen role- and entitlement-controlled portfolio and trading tools.
Validated OHLC

Interactive price chart

Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.

Open full workspace
Interactive price chartInteractive chart loads when this section is visible.
Auditable calculations

Daily technical summary

Calculated from validated daily candles. Descriptive research only.

Calculating technicals…
Intelligence: activity, structure and reported deals

Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.

Company derivatives · NSE

ASTRAZEN futures & options

Expiry structure, futures, option chains and contract research.

Snapshot · timestamp unavailable
No observations

No matching contracts have verified observations for this filter.

DIRECTION · ACTIVITY · DISCLOSURES

ASTRAZEN Intelligence

Stored price, volume, causal structure and reported deals for this stock.

Market map
Checking research access…

Volume and pressure are activity estimates, not net money inflow. Futures and options retain their separate observations above.

Company reporting

Financial statements

IND AS · INR crore

Metric202620252024
Total Liabilities Shareholders' Equity1,989.11,518.121,078.03
Accumulated Depreciation Total-67.29-151.79-120.32
Cash Equivalents425.76509.33486.7
Other Liabilities Total37.7515.326.21
Accrued Expenses58.79101.9655.23
Common Stock Total555
Other Current Assets Total1.7522.11
Prepaid Expenses11.214.2110.96
Total Assets1,989.11,518.121,078.03
Current Portof LT Debt/Capital Leases13.916.281.81
Cash21.9626.8118.87
Total Equity872.79770.35711.92
Long Term Investments3.673.4Not available
Retained Earnings(Accumulated Deficit)861.28758.2703.63
Total Common Shares Outstanding2.52.52.5
Property/Plant/Equipment Total-Gross184.76215.37185.16
Tangible Book Valueper Share Common Eq349.12307.88283.92
Total Liabilities1,116.31747.77366.11
Total Debt110.6635.734.59
Cashand Short Term Investments447.72536.14505.57
Total Receivables Net242.18239.83185.4
Notes Payable/Short Term Debt000
Accounts Receivable-Trade Net214.7186.87155.4
Property/Plant/Equipment Total-Net117.4763.5864.84
Total Current Liabilities981.81703357.12
Total Inventory1,029.34550.17228.67
ESOP Debt Guarantee6.517.153.29
Accounts Payable782.7456.3196.51
Other Currentliabilities Total126.41138.46103.57
Total Long Term Debt96.7529.452.78
Intangibles Net00.662.11
Other Long Term Assets Total55.2846.1923.72
Note Receivable-Long Term80.4961.9454.65
Total Current Assets1,732.191,342.35932.71
Capital Lease Obligations96.7529.452.78
Fundamentals

Valuation and ratios

Valuation

Price to Sale Ratio8.97

Risk and consensus

Source-qualified signals

Risk metrics

Overall RiskModerate risk

Board Risk24.41

Analyst consensus

Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.
Industry context

Peer comparison

Only peers present in the company profile payload are displayed.

Peer data unavailable in the company profile payload.
Shareholding

Ownership

Promoter
75.00%
FII
2.68%
MF
6.01%
Other
16.31%
Corporate actions

Events

  1. board MeetingsQuarterly Results
  2. annual General MeetingAGM
  3. dividendRs.36.0000 per share(1800%)Final Dividend
  4. board MeetingsAudited Results & Final Dividend
  5. annual General MeetingPOM
  6. annual General MeetingPOM
  7. board MeetingsQuarterly Results
  8. board MeetingsQuarterly Results
  9. board MeetingsQuarterly Results
  10. annual General MeetingA.G.M
  11. dividendRs.32.0000 per share(1600%)Dividend
  12. board MeetingsAudited Results & Dividend
  13. annual General MeetingPOM
  14. board MeetingsQuarterly Results
  15. annual General MeetingPOM
  16. board MeetingsQuarterly Results
  17. board MeetingsQuarterly Results
  18. annual General MeetingAGM
  19. dividendRs.24.0000 per share(1200%)Dividend
  20. board MeetingsAudited Results & Dividend
Rusaka Markets Community

Discussion and sentiment for AstraZeneca Pharma India Ltd

Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.

Rusaka Markets Community

Community discussion loads as you approach this section.

Company profile

Business information

What the company does

Not available

Company facts

Industry
Biotechnology & Drugs
Sector
Biotechnology & Drugs
NSE Code
ASTRAZEN
BSE Code
506820
Questions

Stock FAQ

What is the symbol and ISIN of AstraZeneca Pharma India Ltd?

AstraZeneca Pharma India Ltd has the symbol ASTRAZEN and ISIN - INE203A01020.

What is the latest recorded price of AstraZeneca Pharma India Ltd?

The latest available recorded price of AstraZeneca Pharma India Ltd is INR 8,075.50 as of 2026-08-06T20:53:23.053Z. This is a source-stamped snapshot, not a live quote.

What are the year high and year low of AstraZeneca Pharma India Ltd?

Year high: INR 9,850.00. Year low: INR 7,630.00.

What is the market capitalization of AstraZeneca Pharma India Ltd?

Market capitalization: INR 20,400.82 crore.

How is the financial performance of AstraZeneca Pharma India Ltd based on revenue, net income, and EPS?

Revenue: INR 2,275.58 crore. Net income: INR 187.52 crore. EPS is unavailable in the current source.

What are the price-to-book and price-to-sales ratios of AstraZeneca Pharma India Ltd?

Price-to-book ratio is unavailable in the current source. Price-to-sales ratio: 8.97.

Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.